A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Exscientia AI Limited
Varian, a Siemens Healthineers Company
University of California, Irvine
Duke University
Grey Wolf Therapeutics
Takeda
Second Life Therapeutics
RenJi Hospital
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Milton S. Hershey Medical Center
Brigham and Women's Hospital
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Columbia University
Tvardi Therapeutics, Incorporated
Intensity Therapeutics, Inc.
Universidade Federal de Pernambuco
NantBioScience, Inc.
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Comprehensive Support Project for Oncology Research
Pfizer
Celldex Therapeutics
Fusion Pharmaceuticals Inc.
Massachusetts General Hospital
Klus Pharma Inc.
Celldex Therapeutics
Shanghai Yunying Medical Technology
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
Hospices Civils de Lyon
Sun Yat-sen University
Zhujiang Hospital
University Hospital Tuebingen
Stanford University
Butler Hospital
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Santa Maria Biotherapeutics
Roswell Park Cancer Institute
Fox Chase Cancer Center
Curis, Inc.